Recombinant adeno-associated virus mediated gene transfer ina mouse model for homocystinuria

다국어 초록 (Multilingual Abstract)

Homocystinuria is a metabolic disorder caused by a deficiency of cystathionine β-synthase (CBS). The major clinical symptoms of this disease are mental retardation, lens dislocation, vascular disease with life-threatening thromboembolisms, and skeletal deformities. The major treatments for CBS deficiency include pharmacologic doses of pyridoxine or dietary restriction of methionine. There is currently plasma levels of homocysteine. However, gene therapy could be an effective novel approach for the treatment of homocystinuria. A recombinant adeno- associated virus vector carrying human CBS cDNA (rAAV-hCBS) was constructed and administered to CBS-/- mice by intramuscular (IM) and intraperitoneal (IP) injections. Serum homocysteine concentrations significantly decreased in treated mice compared with age-matched controls two weeks after treat-ment. The treated CBS-/- mice had life spans 3-7 days longer compared with untreated CBS-/- mice. In CBS-/- mice treated with rAAV-hCBS via IP injection, the vector was detected in all organs examined including liver, spleen, and kidney, and CBS gene expression the liver. These results indicate the efficacy of gene delivery and demonstrate the possibility of gene therapy mediated by AAV gene transfer in this mouse model of homocystinuria.

참고문헌 (Reference)

1 "cell types and regions in the mammalian central nervous system" 97 : 3428-3432, 2000

2 "Trypsin cleavage of human cys-tathionine beta-synthase into an evolutionarily conserved ac-tive core" 355 : 222-232, 1998

3 "The structure of a domain common to arch-aebacteria and the homocystinuria disease protein" 22 : 12-13, 1997

4 "The natural history of vascular disease in homocystinuria and the effects of treatment" 20 : 295-300, 1997

5 "The natural history of homocystinuria due to cystathionine -synthase deficiency"

6 "The Metabolic and Molecular Bases of Inherited Disease" McGraw-Hill 2007-2056, 2001

7 "Repeat transduction in the mouse lung by using adeno- asso-ciated virus vectors with different serotypes" 74 : 1524-1532, 2000

8 "Regulation of human cystathionine beta-synthase by S-ad-enosyl-L-methionine evidence for two catalytically active con-formations involving an autoinhibitory domain in the C-terminal region" 400 : 10625-10633, 2001

9 "Recombinant adeno-as-sociated virus type 2, 4, and 5 vectors: transduction of variant 660" 38 (38): 652-661, 2006

10 "Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 -CFTR vector in adult cystic fibrosis patients" guggi (guggi): 1079-88,

11 "Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors" 16 : 270-276, 1997

12 "Pathways and regulation of homocysteine me-tabolism in mammals" 26 : 219-225, 2000

13 "Mutations in the regulatory domain of cystathionine beta synthase can functionally suppress patient-derived mutations in cis" 15 : 635-643, 2001

14 "Mice deficient in cystathionine be-ta-synthase animal models for mild and severe homo-cyst" 92 : 1585-1589, 1995

15 "Long-term enzymatic and phenotypic correction in the phenylketonuria mouse mod-el by adeno-associated virus vector mediated gene transfer." 56 : 278-284, 2004

16 "Long- term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer" 99 : 13777-13782, 2002

17 "Hyperhomocysteinemia-an emerging and important risk factor for thromboembolic and cardiovascular disease" 106 : 709-722, 1996

18 "Heterozygosity for homo-cystinuria in premature peripheral and cerebral occlusive arte-rial disease" 709-15,

19 "Expression of the cystathionine beta synthase gene during mouse development and immunolocaliza-tion in adult brain" 51 : 363-371, 2003

20 "Evidence for gene transfer and expression of factor IX in hemo-philia B patients treated with an AAV vector" 24 : 257-261, 2000

21 "Elevated plasma von Willebrand factor in a murine model of severe hyperhomo-cysteinemia" 90 : 362-364, 2003

22 "Effects of betaine in a murine model of mild cystathionine-beta-synthase deficiency" 53 : 594-599, 2004

23 "Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection" 43-52, jchromatogr1987;422

24 "Deletion muta-genesis of human cystathionine beta-synthase Impact on ac-tivity" 277 : 48386-48394, 2002

25 "Cystathionine beta-syn-thase mutations in homocystinuria" 13 : 362-375, 1999

26 "Correction of disease-causing CBS muta-tions in yeast" 13 : 91-93, 1998

27 "Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-defi-cient mice" 22 : 34-41, 2002

28 "Altered gene expression in liver from a murine model of hyperhomo-cysteinemia" 278 : 31504-31511, 2003

29 "Adeno-associated virus-mediated gene therapy" 1 : 166-175, 1999

30 "Adeno-associated viral vectors for gene transfer and gene therapy" 380 : 61322-, 1999

31 "Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple or-gans of Fabry mice" 98 : 2676-2681, 2001

32 "AV vector gene therapy in a mouse model for homocystinuria　661Wilcken DE Homocystinuria due to cystathionine beta-synthase deficiency-the effects of betaine treatment in pyridoxine-responsive patients" 1115-21, metabolism1985;34

33 "AAV-based gene transfer" 5 : 367-375, 2003

34 "AAV- mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B" 101 : 2963-2972, 2003